Efficacy, tolerability, and safety of transition from beraprost to selexipag in patients with pulmonary arterial hypertension.
Latest Information Update: 20 Jun 2022
At a glance
- Drugs Selexipag (Primary) ; Beraprost
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 13 Jun 2022 Status changed from recruiting to completed.
- 04 Jan 2017 Status changed from not yet recruiting to recruiting.
- 16 Dec 2016 New trial record